Subscribe to Newsletter

Cannabinoid analysis

Business & Profession Legislation & policy

The View from Texas

| Kevin Schug

Restrictive legislation won’t prevent efforts to progress cannabis research

Testing & Processing Classification

Not as Advertised

| Matthew Hallam

Apples to oranges… to cannabis. Strain classifications in US dispensaries are not always what they appear.

Research & Development Medical research

Dawn of the (Synthetic) Dope

| Matthew Hallam

Synthetic cannabinoids have become ubiquitous, but how do they exert their 'zombifying' effects?

Business & Profession Pesticide analysis

Time for Testing

| Sponsored by Waters

Cannabis testing: regulation, evolution and the need for nuanced debate.

Testing & Processing Omics

The Genetics – and IP – Guru

| Reggie Gaudino

Reggie Gaudino on sequencing strains and the storm brewing in cannabis IP

Research & Development Neurology & psychology

Fishing for Answers

| Matthew Hallam

Cannabinoid receptor 2 exerts behavioural effects in zebrafish - and may do in humans, too.

Business & Profession Profession

Turning Over a New Leaf

Sitting Down With... Jessica Kristof, Vice President of Research and Development, Phylos Bioscience, Portland, Oregon, USA.

Testing & Processing Cannabinoid analysis

A View From the Biosynthetic Bridge

What are biosynthetic cannabinoids? And what do they mean for pharma?

Testing & Processing Cannabinoid analysis

Cannabis Complex

How unravelling the complex chemistry of the cannabis plant can lead to new medicines

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine

Register